# Wafd Inc: financial statements, quarterly

WAFD · Nasdaq · CIK 936528 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/wafd.md) · [Financials](/companies/wafd/financials.md) · [Filings](/companies/wafd/filings.md) · [Insiders](/companies/wafd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wafd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.8 d](/filings/0000936528-25-000117.md) | [6.8](/filings/0000936528-25-000040.md) | [6.7](/filings/0000936528-25-000063.md) | [7.0](/filings/0000936528-25-000086.md) | [7.0 d](/filings/0000936528-25-000117.md) | [7.0](/filings/0000936528-26-000020.md) | [7.1](/filings/0000936528-26-000043.md) | [7.6](/filings/0000936528-26-000061.md) | [8.0 d](/filings/0000936528-25-000117.md) | [7.9](/filings/0000936528-26-000020.md) | [7.7](/filings/0000936528-26-000043.md) | [8.1](/filings/0000936528-26-000061.md) |
| Interest expense | $m | [118 d](/filings/0000936528-23-000207.md) | [135](/filings/0000936528-24-000037.md) | [160](/filings/0000936528-24-000072.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.9 d](/filings/0000936528-25-000117.md) | [13.2](/filings/0000936528-25-000040.md) | [5.1](/filings/0000936528-25-000063.md) | [18.2](/filings/0000936528-25-000086.md) | [19.5 d](/filings/0000936528-25-000117.md) | [13.0](/filings/0000936528-26-000020.md) | [15.8](/filings/0000936528-26-000043.md) | [17.8](/filings/0000936528-26-000061.md) | [17.0 d](/filings/0000936528-25-000117.md) | [18.1](/filings/0000936528-26-000020.md) | [18.3](/filings/0000936528-26-000043.md) | [18.2](/filings/0000936528-26-000061.md) |
| Net income | $m | [50.2 d](/filings/0000936528-25-000117.md) | [58.5](/filings/0000936528-25-000040.md) | [15.9](/filings/0000936528-25-000063.md) | [64.6](/filings/0000936528-25-000086.md) | [61.1 d](/filings/0000936528-25-000117.md) | [47.3](/filings/0000936528-26-000020.md) | [56.3](/filings/0000936528-26-000043.md) | [62.0](/filings/0000936528-26-000061.md) | [60.6 d](/filings/0000936528-25-000117.md) | [64.2](/filings/0000936528-26-000020.md) | [65.5](/filings/0000936528-26-000043.md) | [66.1](/filings/0000936528-26-000061.md) |
| Diluted EPS | $ per share | not reported | [0.85](/filings/0000936528-25-000040.md) | [0.17](/filings/0000936528-25-000063.md) | [0.75](/filings/0000936528-25-000086.md) | not reported | [0.54](/filings/0000936528-26-000020.md) | [0.65](/filings/0000936528-26-000043.md) | [0.73](/filings/0000936528-26-000061.md) | not reported | [0.79](/filings/0000936528-26-000020.md) | [0.82](/filings/0000936528-26-000043.md) | [0.84](/filings/0000936528-26-000061.md) |
| Basic EPS | $ per share | not reported | [0.85](/filings/0000936528-25-000040.md) | [0.17](/filings/0000936528-25-000063.md) | [0.75](/filings/0000936528-25-000086.md) | not reported | [0.54](/filings/0000936528-26-000020.md) | [0.65](/filings/0000936528-26-000043.md) | [0.73](/filings/0000936528-26-000061.md) | not reported | [0.79](/filings/0000936528-26-000020.md) | [0.82](/filings/0000936528-26-000043.md) | [0.85](/filings/0000936528-26-000061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000936528-24-000164.md) | [1.1](/filings/0000936528-24-000037.md) | [1.5](/filings/0000936528-24-000072.md) | [2.5](/filings/0000936528-24-000110.md) | [2.4](/filings/0000936528-25-000117.md) | [1.5](/filings/0000936528-25-000040.md) | [1.2](/filings/0000936528-25-000063.md) | [0.8](/filings/0000936528-25-000086.md) | [0.7](/filings/0000936528-26-000061.md) | [0.7](/filings/0000936528-26-000020.md) | [0.7](/filings/0000936528-26-000043.md) | [0.7](/filings/0000936528-26-000061.md) |
| Total assets | $bn | [22.5](/filings/0000936528-24-000164.md) | [22.6](/filings/0000936528-24-000037.md) | [30.1](/filings/0000936528-24-000072.md) | [28.6](/filings/0000936528-24-000110.md) | [28.1](/filings/0000936528-25-000117.md) | [27.7](/filings/0000936528-25-000040.md) | [27.6](/filings/0000936528-25-000063.md) | [26.7](/filings/0000936528-25-000086.md) | [26.7](/filings/0000936528-26-000061.md) | [27.3](/filings/0000936528-26-000020.md) | [27.6](/filings/0000936528-26-000043.md) | [27.6](/filings/0000936528-26-000061.md) |
| Total liabilities | $bn | [20.0](/filings/0000936528-24-000164.md) | [20.2](/filings/0000936528-24-000037.md) | [27.2](/filings/0000936528-24-000072.md) | [25.6](/filings/0000936528-24-000110.md) | [25.1](/filings/0000936528-25-000117.md) | [24.7](/filings/0000936528-25-000040.md) | [24.6](/filings/0000936528-25-000063.md) | [23.7](/filings/0000936528-25-000086.md) | [23.7](/filings/0000936528-26-000061.md) | [24.3](/filings/0000936528-26-000020.md) | [24.6](/filings/0000936528-26-000043.md) | [24.6](/filings/0000936528-26-000061.md) |
| Shareholders' equity | $bn | [2.4](/filings/0000936528-25-000117.md) | [2.5](/filings/0000936528-25-000063.md) | [2.9](/filings/0000936528-25-000086.md) | [3.0](/filings/0000936528-25-000086.md) | [3.0](/filings/0000936528-26-000061.md) | [3.0](/filings/0000936528-26-000043.md) | [3.0](/filings/0000936528-26-000061.md) | [3.0](/filings/0000936528-26-000061.md) | [3.0](/filings/0000936528-26-000061.md) | [3.0](/filings/0000936528-26-000043.md) | [3.0](/filings/0000936528-26-000061.md) | [3.0](/filings/0000936528-26-000061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [82.9 d](/filings/0000936528-25-000117.md) | [110](/filings/0000936528-25-000040.md) | [169 d](/filings/0000936528-25-000063.md) | [63.2 d](/filings/0000936528-25-000086.md) | [96.6 d](/filings/0000936528-25-000117.md) | [49.4](/filings/0000936528-26-000020.md) | [72.1 d](/filings/0000936528-26-000043.md) | [58.0 d](/filings/0000936528-26-000061.md) | [57.4 d](/filings/0000936528-25-000117.md) | [60.5](/filings/0000936528-26-000020.md) | [79.4 d](/filings/0000936528-26-000043.md) | [70.3 d](/filings/0000936528-26-000061.md) |
| Capital expenditure | $m | [3.8 d](/filings/0000936528-25-000117.md) | [8.2](/filings/0000936528-25-000040.md) | [4.4 d](/filings/0000936528-25-000063.md) | [4.9 d](/filings/0000936528-25-000086.md) | [7.2 d](/filings/0000936528-25-000117.md) | [6.4](/filings/0000936528-26-000020.md) | [5.6 d](/filings/0000936528-26-000043.md) | [4.9 d](/filings/0000936528-26-000061.md) | [11.8 d](/filings/0000936528-25-000117.md) | [10.4](/filings/0000936528-26-000020.md) | [11.4 d](/filings/0000936528-26-000043.md) | [6.9 d](/filings/0000936528-26-000061.md) |
| Dividends paid | $m | [16.0 d](/filings/0000936528-25-000117.md) | [16.0](/filings/0000936528-25-000040.md) | [16.5 d](/filings/0000936528-25-000063.md) | [20.9 d](/filings/0000936528-25-000086.md) | [20.9 d](/filings/0000936528-25-000117.md) | [20.9](/filings/0000936528-26-000020.md) | [21.6 d](/filings/0000936528-26-000043.md) | [21.2 d](/filings/0000936528-26-000061.md) | [20.9 d](/filings/0000936528-25-000117.md) | [20.4](/filings/0000936528-26-000020.md) | [20.2 d](/filings/0000936528-26-000043.md) | [19.7 d](/filings/0000936528-26-000061.md) |
| Share repurchases | $m | [0.0 d](/filings/0000936528-25-000117.md) | [17.1](/filings/0000936528-25-000040.md) | [0.2 d](/filings/0000936528-25-000063.md) | [9.5 d](/filings/0000936528-25-000086.md) | [0.3 d](/filings/0000936528-25-000117.md) | [3.4](/filings/0000936528-26-000020.md) | [21.3 d](/filings/0000936528-26-000043.md) | [48.3 d](/filings/0000936528-26-000061.md) | [28.8 d](/filings/0000936528-25-000117.md) | [58.0](/filings/0000936528-26-000020.md) | [87.2 d](/filings/0000936528-26-000043.md) | [0.3 d](/filings/0000936528-26-000061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.4](/filings/0000936528-24-000037.md) | [65.6](/filings/0000936528-24-000072.md) | [65.2](/filings/0000936528-24-000110.md) | [64.3](/filings/0000936528-25-000040.md) | [70.2](/filings/0000936528-25-000063.md) | [81.4](/filings/0000936528-25-000086.md) | [81.4](/filings/0000936528-26-000020.md) | [81.1](/filings/0000936528-26-000043.md) | [79.9](/filings/0000936528-26-000061.md) | [77.0](/filings/0000936528-26-000020.md) | [75.6](/filings/0000936528-26-000043.md) | [74.0](/filings/0000936528-26-000061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 73,995,238 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000936528-26-000061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.